Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / Class A Common Stock, $0.0001 par value per share
-
Shares outstanding
-
23.9M
-
Number of holders
-
31
-
Total 13F shares, excl. options
-
1.85M
-
Shares change
-
+121K
-
Total reported value, excl. options
-
$3.85M
-
Value change
-
+$220K
-
Put/Call ratio
-
0.85
-
Number of buys
-
10
-
Number of sells
-
-9
-
Price
-
$2.08
Significant Holders of Celularity Inc - Class A Common Stock, $0.0001 par value per share (CELU) as of Q4 2024
37 filings reported holding CELU - Celularity Inc - Class A Common Stock, $0.0001 par value per share as of Q4 2024.
Celularity Inc - Class A Common Stock, $0.0001 par value per share (CELU) has 31 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.85M shares
of 23.9M outstanding shares and own 7.73% of the company stock.
Largest 10 shareholders include C V STARR & CO INC (764K shares), VANGUARD GROUP INC (500K shares), GEODE CAPITAL MANAGEMENT, LLC (132K shares), BlackRock, Inc. (102K shares), STATE STREET CORP (65.4K shares), TWO SIGMA INVESTMENTS, LP (44.9K shares), HB Wealth Management, LLC (40.1K shares), Biltmore Family Office, LLC (35K shares), NORTHERN TRUST CORP (34.1K shares), and KEYNOTE FINANCIAL SERVICES LLC (25K shares).
This table shows the top 31 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.